Clincosm LogoSign in Get a demo

Myeloma Multiple

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Myeloma Multiple Trial (Connected scale "Body Comp Pro" from Withings)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Myeloma Multiple
  • Connected scale "Body Comp Pro" from Withings
  • (no location specified)
Nov 9, 2023

Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

Not yet recruiting
  • Myeloma Multiple
  • Dasatinib 100 MG
  • Chia, Cundinamarca, Colombia
    CAIMED
Jul 12, 2023

Myeloma Multiple Trial (Off Drug Surveillance)

Not yet recruiting
  • Myeloma Multiple
  • Off Drug Surveillance
  • (no location specified)
Jun 27, 2023

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Corneal Toxicity in Patients Treated by Belantamab Mafodotin

Completed
  • Myeloma Multiple
  • Collection of datas
  • Dijon, France
  • +9 more
May 31, 2023

Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

Terminated
  • Myeloma Multiple
  • +2 more
  • Brooklyn, New York
  • +1 more
Jan 24, 2023

Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Jan 12, 2023

Stratification in Multiple Myeloma Based on Fluorescence Flow

Recruiting
  • Myeloma Multiple
  • fluorescence flow cytometry
  • Saint Petersburg, Russian Federation
    Boris V Afanasyev, MD, Prof.
Jul 19, 2022

Myeloma Multiple Trial (Traditional Control, Oral Nutritional Supplement)

Not yet recruiting
  • Myeloma Multiple
  • Traditional Control
  • Oral Nutritional Supplement
  • (no location specified)
Jul 12, 2022

Myeloma Multiple, Lymphoma Trial in Monterrey (Pegfilgrastim)

Recruiting
  • Myeloma Multiple
  • Lymphoma
  • Monterrey, Nuevo León, Mexico
    Hospital Universitario Dr. José Eleuterio González
Apr 18, 2022

Myeloma Multiple, Lymphoma Trial in Maastricht (Vitamin C, Placebos)

Completed
  • Myeloma Multiple
  • Lymphoma
  • Vitamin C
  • Placebos
  • Maastricht, Limburg, Netherlands
    MUMC+
Apr 19, 2022

Myeloma Multiple Trial in Orange, Nashville (Descartes 08)

Recruiting
  • Myeloma Multiple
  • Descartes 08
  • Orange, California
  • +1 more
Apr 4, 2022

Myeloma Multiple Trial in Pessac (Positron Emission Tomography using 18F-FCH, Positron Emission Tomography using 18F-FDG)

Recruiting
  • Myeloma Multiple
  • Positron Emission Tomography using 18F-FCH
  • Positron Emission Tomography using 18F-FDG
  • Pessac, France
    Bordeaux University Hospital - Haut-Lévêque
Mar 30, 2022

Myeloma Multiple Trial in United States (Descartes 11)

Completed
  • Myeloma Multiple
  • Descartes 11
  • Bethesda, Maryland
  • +3 more
Mar 10, 2022

COVID-19 After Autologous Hematopoietic Stem Cell

Completed
  • Covid19
  • +4 more
  • Autologous stem cell transplantation
  • Uppsala, Sweden
    Uppsala Universitet
Feb 7, 2022

Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

Completed
  • Myeloma Multiple
  • +3 more
  • Afula, Israel
  • +13 more
Jan 26, 2022

Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

Recruiting
  • Multiple Myeloma
  • +6 more
  • Tucson, Arizona
  • +9 more
Jan 5, 2022

Myeloma Multiple Trial in Houston (Belantamab mafodotin, Lenalidomide)

Not yet recruiting
  • Myeloma Multiple
  • Houston, Texas
    MD Anderson Cancer Center
Oct 29, 2021

Haematological Malignancy, Leukemia, Acute, Lymphoma Trial in Kuala Lumpur (WHODAS 2.0 Questionnaire)

Completed
  • Haematological Malignancy
  • +5 more
  • WHODAS 2.0 Questionnaire
  • Kuala Lumpur, Wilayah Persekutuan, Malaysia
    University Malaya
Nov 2, 2020

CTFEA Myeloma Study

Not yet recruiting
  • Myeloma Multiple
  • Metastatic Bone Tumor
  • CT-based finite element analysis
  • (no location specified)
Apr 23, 2020

Myeloma Multiple Trial in Siena (Daratumumab)

Recruiting
  • Myeloma Multiple
  • Siena, Italy
    Azienda Ospedaliera Universitaria Senese
Jun 17, 2019

Myeloma Multiple Trial in Birmingham, London, Southampton (Cyclophosphamide, Lenalidomide, Pembrolizumab)

Withdrawn
  • Myeloma Multiple
  • Birmingham, United Kingdom
  • +3 more
Aug 22, 2017

Collection of Additional Data Followed the Study IFM 2013-04

Unknown status
  • Myeloma Multiple
    • Annecy, Pringy,, France
    • +62 more
    Mar 23, 2017